The importance of patient positioning

In this post we discuss a case study detailing the importance of properly positioning and land marking the patient when performing a NeuroQuant® volumetric analysis.

glabellarWhen positioning a patient on the MRI table, land marking the X, Y and Z coordinates in the glabellar region is critical (see image). Land marking the patient in this region of the head, specifically the area between the eyebrows and above the nose, allows the center of the brain to align with the isocenter of the magnetic field. Magnetic field inhomogeneties are at their smallest magnitudes in isocenter. Therefore, positioning the head away from the isocenter in the + or – direction will cause greater distortion introduced by gradient nonlinearity.

If a sequence is acquired and uploaded to NeuroQuant with any of the X, Y or Z coordinates outside +/-100mm, automated volumetric analysis cannot be performed. An error message will be returned to the queue monitor and/or PACS. Below is an example of the NeuroQuant error message that would be generated in this case.

Unsuccessful patient positioning

Automated volumetric analysis is not possible in these instances. If NeuroQuant returns such an error message, re-scanning the patient with the scan origin centered appropriately is advisable.

Important note: If your patient is having an MRI performed on a body part other than the brain (i.e. cervical, thoracic, lumbar spine) it is very important to re-establish the glabellar region of the head as isocenter prior to acquiring the NeuroQuant volumetric scan.

Interested in learning more about how to ensure accurate NeuroQuant output results?

  • Explore the importance of using a 3D T1 sagittal MRI sequences for NeuroQuant analysis. You can read that blog post here.
  • Review how to ensure accurate NeuroQuant processing results. You can read that blog post here.
  • Understand why contrast agents are not used to achieve quality segmentation with NeuroQuant. You can read that blog post here.
  • Examine why good alignment to atlas is necessary. You can read that blog post here.

Additionally, more information about using and processing NeuroQuant can be found here.

References:

  1. Caramanos Z. et al. Gradient distortions in MRI: characterizing and correcting for their effects on SIENNA-generated measure of brain volume change. Neuroimage, 2010, Jan15:49(2):1601-11.
  1. Velthuizen R. et al. Review and evaluation of MRI nonuniformity for brain tumor response measurements. Med. phys. 25, 1655(1998).

Cortechs.ai | The importance of patient positioning

More Resources

08/19/2026

Brain Metastases Imaging Insights from SNO/ASCO 2026

Explore key insights from SNO/ASCO 2026 on brain metastases imaging, including lesion tracking, volumetric analysis, SRS workflows, and automated segmentation.

08/18/2026

Cortechs.ai Announces FDA Clearance for NeuroQuant® PET: Advancing Molecular Imaging for Cognitive Impairment

NeuroQuant® PET receives FDA 510(k) clearance, advancing quantitative PET imaging for cognitive impairment.

08/04/2026

Cortechs.ai Expands European CE Marking Across AI Imaging Platform, Accelerating Global Growth

Cortechs.ai expands EU CE Marking for the latest NeuroQuant®, NeuroQuant® Brain Tumor, and OnQ™ Prostate, advancing global AI imaging innovation

07/29/2026

Read Your Segmentations in the Same Space You Read the Study: Native Space Outputs in NeuroQuant v5.3.0

Review lesion segmentations directly on your original MRI images with NeuroQuant® v5.3.0.

07/23/2026

What AAIC 2026 Told Us About the Future of Dementia Imaging — And Where NeuroQuant Fits

Quantitative MRI brain volumetry with NeuroQuant.

07/09/2026

Viz.ai Expands into Neurodegenerative Disease with Cortechs.ai Collaboration

Cortechs.ai and Viz.ai partner to tackle multiple sclerosis and other neurodegenerative diseases across Viz.ai’s health system network
Scroll to Top